11. Emery A. E. The muscular dystrophies. Lancet, 2002, vol. 359, no. 9307, pp. 687-695. https://doi. org/10.1016/S0140-6736(02)07815-7
12. Bienias P, tusakowska A., Ciurzynski M., Rymarczyk Z., Irzyk K., Kurnicka K., Kaminska A., Pruszc- zyk P Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status. Pacing Clin. Electrophysiol., 2016, vol. 39, no. 9, pp. 959-968. https://doi.org/10.1111/pace.12924
13. Kulach A., Majewski M., G^sior Z., Gardas R., Goscinska-Bis K., Golba K. S. Dilated cardiomyopathy with severe arrhythmias in Emery-Dreifuss muscular dystrophy. Cardiol J., 2020, vol. 27, no. 1, pp. 93-94. https://doi.org/10.5603/CJ.2020.0021
14. Carlisle M. A., Fudim M., DeVore A. D., Piccini J. P Heart Failure and Atrial Fibrillation, Like Fire and Fury. JACC Heart Fail., 2019, vol. 7, no. 6, pp. 447-456. https://doi.org/10.1016/j.jchf.2019.03.005
15. Prabhu S., Voskoboinik A., Kaye D. M., Kistler P M. Atrial Fibrillation and Heart Failure -- Cause or Effect? Heart Lung Circ., 2017, vol. 26, no. 9, pp. 967-974. https://doi.org/10.1016/j.hlc.2017.05.117
16. Brachmann J., Sohns C., Andresen D., Siebels J., Sehner S., Boersma L., Merkely B., Pokushalov E., Sanders P, Schunkert H., Bansch D., Dagher L., Zhao Y., Mahnkopf C., Wegscheider K., Mar- rouche N. F. Atrial Fibrillation Burden and Clinical Outcomes in Heart Failure: The CASTLE-AF Trial. JACC Clin. Electrophysiol., 2021, vol. 7, no. 5, pp. 594-603. https://doi.org/10.1016/j.jacep.2020.11.021
17. Al-Falahi Z., Williamson J., Dimitri H. Atrial Fibrillation and Sleep Apnoea: Guilt by Association? Heart Lung Circ., 2017, vol. 26, no. 9, pp. 902-910. https://doi.org/10.1016/j.hlc.2017.05.127
18. Kwon Y., Koene R. J., Johnson A. R., Lin G.-M., Ferguson J. D. Sleep, sleep apnea and atrial fibrillation: Questions and answers. Sleep Med. Rev., 2018, vol. 39, pp. 134-142. https://doi.org/10.1016Zj. smrv.2017.08.005
19. Huang B., Liu H., Scherlag B. J., Sun L., Xing S., Xu J., Luo M., Guo Y., Cao G., Jiang H. Atrial fibrillation in obstructive sleep apnea: Neural mechanisms and emerging therapies. Trends Cardiovasc. Med., 2021, vol. 31, no. 2, pp. 127-132. https://doi.org/10.1016/j.tcm.2020.01.006
20. Mehra R. Sleep apnea and the heart. Cleve Clin. J. Med., 2019, vol. 86 (9 Suppl 1), pp. 10-18. https://doi. org/10.3949/ccjm.86.s1.03
21. Qin D., Mansour M. C., Ruskin J. N., Heist E. K. Atrial Fibrillation-Mediated Cardiomyopathy. Circ. Arrhythm. Electrophysiol., 2019, vol. 12, no. 12, e007809. https://doi.org/10.1161/CIRCEP119.007809
22. Ali-Ahmed F., Dalgaard F., Al-Khatib S. M. Sudden cardiac death in patients with myocarditis: Evaluation, risk stratification, and management. Am. Heart J., 2020, vol. 220, pp. 29-40. https://doi. org/10.1016/j.ahj.2019.08.007
23. Gordeeva M. V, Veleslavova O. E., Baturova M. A., Rylov A. Yu., Lavrentyuk G. P, Platonov P G., Shubik Yu. V. Suddent non-violent death in young adults (retrospective analysis). Journal of ar- rhythmology, 2011, no. 65, pp. 25-32. (In Russian)
24. Gordeeva M. V, Mitrofanova L. B., Pahomov A. V, Velesvlavova O. E., Berman M. V, Lavtentyuk G. P, Platonov P G., Shubik Yu. V Sudden cardiac death of young people. Journal of arrhythmology, 2012, no. 68, pp. 34-44. (In Russian)
25. Wilkinson C., Todd O., Clegg A., Gale C. P, Hall M. Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis. Age Ageing, 2019, vol. 48, no. 2, pp. 196-203. https://doi.org/10.1093/ageing/afy180
26. Shcolnikova M. A., Shubik Yu. V, Shalnova S. A., Shcolnikov V. M., Waupel D. Cardiac arrhythmias in the elderly and their association with health characteristics and mortality. Journal of arrhythmology, 2007, no. 49, pp. 5-13. (In Russian)
27. Wong C. X., Sun M., Mahajan R., Mahajan R., Pathak R. K., Middeldorp M., Twomey D., Gane- san A. N., Rangnekar G., Roberts-Thomson K. C., Lau D. H., Sanders P Obesity and the risk of incident, post-operative and post ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC Clin. Electrophysiol., 2015, vol. 1, no. 3, pp. 139-152. https://doi.org/10.1016/j.ja- cep.2015.04.004
28. Batal O., Schoenhagen P, Shao M., Ayyad A. E., Van Wagoner D. R., Halliburton S. S., Tchou P J., Chung M. K. Left atrial epicardial adiposity and atrial fibrillation. Circ. Arrhythm. Electrophysiol., 2010, vol. 3, no. 3, pp. 230-236. https://doi.org/10.1161/CIRCEP.110.957241
29. Pathak R. K., Middeldorp M. E., Lau D. H., Mehta A. B., Mahajan R., Twomey D., Alasady M., Hanley L., Antic N. A., McEvoy R. D., Kalman J. M., Abhayaratna W. P, Sanders P Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J.Am. Coll. Cardiol., 2014, vol. 64, no. 21, pp. 2222-2231. https://doi.Org/10.1016/j. jacc.2014.09.028
30. Wang A., Green J. B., Halperin J. L., Piccini J. P. Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week. J. Am. Coll. Cardiol., 2019, vol. 74, no. 8, pp. 1107-1115. https://doi.org/10.1016/j. jacc.2019.07.020
31. Goudis C. A., Korantzopoulos P., Ntalas I. V., Kallergis E. M., Liu T., Ketikoglou D. G. Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies. Int. J. Cardiol., 2015, vol. 1, no. 184, pp. 617-622. https://doi.org/10.1016/j.ijcard.2015.03.052
32. Tadic M., Cuspidi C. Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice. Arch. Cardiovasc. Dis., 2015, vol. 108, no. 4, pp. 269-276. https://doi.org/10.1016/j. acvd.2015.01.009
33. Pallisgaard J. L., Schjerning A. M., Lindhardt T. B., Procida K., Hansen M. L., Torp-Pedersen Ch., Gisla- son G. H. Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study. Eur. J. Prev. Cardiol., 2016, vol. 23, no. 6, pp. 621-627. https://doi.org/10.1177/2047487315599892
34. Westermann D., Schrage B. Mitral stenosis and atrial fibrillation. Heart, 2020, vol. 106, no. 10, pp. 713. https://doi.org/10.1136/heartjnl-2019-316282
35. Iung B., Leenhardt A., Extramiana F. Management of atrial fibrillation in patients with rheumatic mitral stenosis. Heart, 2018, vol. 104, no. 13, pp. 1062-1068. https://doi.org/10.1136/heartjnl-2017-311425
36. Iung B., Algalarrondo V. Atrial Fibrillation and Aortic Stenosis: Complex Interactions Between 2 Diseases. JACC Cardiovasc. Interv., 2020, vol. 13, no. 18, pp. 2134-2136. https://doi.org/10.1016/j. jcin.2020.06.028
37. Shekhar S., Saad A., Isogai T., Abushouk A., Bansal A., Khubber S., Vaidya P., Gad M. M., Verma B. R., Kapadia S. R. Impact of Atrial Fibrillation in Aortic Stenosis (From the United States Readmissions Database). Am. J. Cardiol., 2021, vol. 140, pp. 154-156. https://doi.org/10.1016/j.amjcard.2020.11.021
38. Bax J. J., Marsan N. A., Delgado V. Non-invasive imaging in atrial fibrillation: focus on prognosis and catheter ablation. Heart, 2015, vol. 101, no. 2, pp. 94-100. https://doi.org/10.1136/heartjnl-2013-305150
39. Hoit B. D. Left atrial size and function: role in prognosis. J. Am. Coll. Cardiol., 2014, vol. 63, no. 6, pp. 493-505. https://doi.org/10.1016/j.jacc.2013.10.055
40. McGann C., Akoum N., Patel A., Kholmovski E., Revelo P., Damal K., Wilson B., Cates J., Harrison A., Ranjan R., Burgon N. S., Greene T., Kim D., Dibella E. V. R., Parker D., Macleod R. S., Marrouche N. F. Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ. Arrhythm. Electrophysiol., 2014, vol. 7, no. 1, pp. 23-30. https://doi.org/10.1161/CIRCEP.113.000689
41. Daccarett M., Badger T. J., Akoum N., Burgon N. S., Mahnkopf C., Vergara G., Kholmovski E., McGann C. J., Dennis Parker D., Brachmann J., MacLeod R. S., Nassir F. Marrouche N. F. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J. Am. Coll. Cardiol., 2011, vol. 57, no. 7, pp. 831-838. https:// doi.org/10.1016/j.jacc.2010.09.049
42. Marrouche N. F., Wilber D., Hindricks G., Jais P., Akoum N., Marchlinski F., Kholmovski E., Burgon N., Hu N., Mont L., Deneke T., Duytschaever M., Neumann T., Mansour M., Mahnkopf C., Herweg B., Daoud E., Wissner E., Bansmann P., Brachmann J. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA, 2014, vol. 311, no. 5, pp. 498-506. https://doi.org/10.1001/jama.2014.3
43. Marrouche N. F., Brachmann J., Andresen D., Siebels J., Boersma L., Jordaens L., Merkely B., Pokusha- lov E., Sanders P., Proff J., Schunkert H., Christ H., Vogt J., Bansch D. Catheter Ablation for Atrial Fibrillation with Heart Failure. N. Engl. J. Med., 2018, vol. 378, no. 5, pp. 417-427. https://doi.org/10.1056/ NEJMoa1707855
44. Lip G. Y., Halperin J. L. Improving stroke risk stratification in atrial fibrillation. Am. J. Med., 2010, vol. 123, no. 6, pp. 484-488. https://doi.org/10.1016/j.amjmed.2009.12.013
45. Glotzer T. V., Daoud E. G., Wyse D. G., Singer D. E., Ezekowitz M. D., Hilker C., Miller C., Qi D., Ziegler P. D. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ. Arrhythm. Electrophysiol., 2009, vol. 2, no. 5, pp. 474-480. https://doi.org/10.1161/CIRCEP.109.849638
46. Healey J. S., Connolly S. J., Gold M. R., Israel C. W., Van Gelder I. C., Capucci A., Lau C. P., Fain E., Yang S., Bailleul Ch., Morillo C. A., Carlson M., Themeles E., Kaufman E. S., Hohnloser S. H. Subclini- cal atrial fibrillation and the risk of stroke. N. Engl. J. Med., 2012, vol. 366, no. 2, pp. 120-129. https:// doi.org/10.1056/NEJMoa1105575
47. Brambatti M., Connolly S. J., Gold M. R., Morillo C. A., Capucci A., Muto C., Lau C. P., Van Gelder I. C., Hohnloser S. H., Carlson M., Fain E., Nakamya J., Mairesse G. H., Halytska M., Deng W. Q., Israel C. W., Healey J. S. Temporal relationship be tween subclinical atrial fibrillation and embolic events. Circulation, 2014, vol. 129, no. 21, pp. 2094-2099. https://doi.org/10.1161/aRCULATIONAHA.113.007825
48. Ip J., Waldo A. L., Lip G. Y., Rothwell P. M., Martin D. T., Bersohn M. M., Choucair W. K., Akar J. G., Wathen M. S., Rohani P., Halperin J. L. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort. Am. Heart J., 2009, vol. 158, no. 3, pp. 364-370. https://doi.org/10.1016Aj.ahj.2009.07.002
49. Martin D. T., Bersohn M. M., Waldo A. L., Wathen M. S., Choucair W. K., Lip G. Y. H., Ip J., Holcomb R., Akar J. G., Halperin J. L. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation. Eur. Heart J., 2015, vol. 36, no. 26, pp. 1660-168. https://doi.org/10.1093/eurheartj/ehv115
50. Dubrey S., Pollak A., Skinner M., Falk R. H. Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br. Heart J., 1995, vol. 74, no. 5, pp. 541-544. https://doi.org/10.1136/hrt.74.5.541
51. Nattel S. Close connections between contraction and rhythm: a new genetic cause of atrial fibrillation/ cardiomyopathy and what it can teach us. Eur. Heart J., 2017, vol. 38, no. 1, pp. 35-37. https://doi. org/10.1093/eurheartj/ehw457
52. Fuster V., Gersh B. J., Giuliani E. R., Tajik A. J., Brandenburg R. O., Frye R. L. The natural history of idiopathic dilated cardiomyopathy. Am. J. Cardiol., 1981, vol. 47, no. 3, pp. 525-531. https://doi. org/10.1016/0002-9149(81)90534-8
53. Healey J. S., Baranchuk A., Crystal E., Morillo C. A., Garfinkle M., Yusuf S., Connolly S. J. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J. Am. Coll. Cardiol., 2005, vol. 45, no. 11, pp. 1832-1839. https://doi.org/10.1016/j. jacc.2004.11.070
54. Kishlay A. K., Mooss A. N., Hee T. T., Mohiuddin S. M. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation. Am. Heart J., 2006, vol. 152, no. 2, pp. 217-222. https:// doi.org/10.1016/j.ahj.2006.01.007
55. Zannad F., Alla F., Dousset B., Perez A., Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation, 2000, vol. 102, no. 22, pp. 2700-2706. https://doi.org/10.1161/01.cir.102.22.2700
56. Pitt B., Remme W., Zannad F., Neaton J., Martinez F., Roniker B., Bittman R., Hurley S., Kleiman J., Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med., 2003, vol. 348, no. 14, pp. 1309-1321. https://doi.org/10.1056/ NEJMoa030207
57. Wang Z., Zhang Y., Gao M., Wang J., Wang Q., Wang X., Su L., Hou Y. Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Pharmacotherapy, 2011, vol. 31, no. 11, pp. 1051-1062. https://doi.org/10.1592/phco.31.11.1051
58. Sai C., Li J., Ruiyan M., Yingbin X. Atorvastatin prevents postoperative atrial fibrillation in patients undergoing cardiac surgery. Hellenic J. Cardiol., 2019, vol. 60, no. 1, pp. 40-47. https://doi.org/10.1016/j. hjc.2017.12.012
59. Calder P. C. N-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J. Clin. Nutr., 2006, vol. 83, 6 Suppl, pp. 1505-1519. https://doi.org/10.1093/ajcn/83.6.1505S
60. Calo L., Bianconi L., Colivicchi F., Lamberti F., Loricchio M. L., De Ruvo E., Meo A., Pandozi C., Stai- bano M., Santini M. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J. Am. Coll. Cardiol., 2005, vol. 45, no. 10, pp. 1723-1728. https://doi.org/10.1016/j.jacc.2005.02.079
61. Al-Shawabkeh Z., Al-Nawaesah K., Abu Anzeh R., Al-Odwan H., Azyoud W., Al-Rawashdeh B., Al- taani H. Use of short-term steroids in the prophylaxis of atrial fibrillation after cardiac surgery. J. Saudi Heart Assoc., 2017, vol. 29, no. 1, pp. 23-29. https://doi.org/10.1016/j.jsha.2016.03.005
62. Shiroshita-Takeshita A., Schram G., Lavoie J., Nattel S. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation, 2004, vol. 110, no. 16, pp. 2313-2319. https://doi.org/10.1161/01.CIR.0000145163.56529.D1
63. Putzu A., Daems A.-M., Lopez-Delgado J. C., Giordano V F., Landoni G. The Effect of Vitamin C on Clinical Outcome in Critically Ill Patients: A Systematic Review with Meta-Analysis of Randomized Controlled Trials. Crit. Care Med., 2019, vol. 47, no. 6, pp. 774-783. https://doi.org/10.1097/ CCM.0000000000003700
64. Lemola K., Desjardins B., Sneider M., Case I., Chugh A., Good E., Han J., Tamirisa K., Tsemo A., Reich S., Tschopp D., Igic P., Elmouchi D., Bogun F., Pelosi F., Kazerooni E., Morady F., Oral H. Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. Heart Rhythm, 2005, vol. 2, no. 9, pp. 923-928. https://doi.org/10.1016/j.hrthm.2005.06.026
65. Verma A., Kilicaslan F., Adams J. R., Hao S., Beheiry S., Minor S., Ozduran V, Elayi S. C., Martin D. O., Schweikert R. A., Saliba W, Thomas J. D., Garcia M., Klein A., Natale A. Extensive ablation during pulmonary vein antrum isolation has no adverse impact on left atrial function: an echocardiography and cine computed tomography analysis. J. Cardiovasc. Electrophysiol., 2006, vol. 17, no. 7, pp. 741-746. https://doi.org/10.1111/j.1540-8167.2006.00488.x
66. Belen E., Ozal E., Pusuroglu H. Association of the CHA2DS2-VASc score with left atrial spontaneous echo contrast: a cross-sectional study of patients with rheumatic mitral stenosis in sinus rhythm. Heart Vessels, 2016, vol. 31, no. 9, pp. 1537-1543. https://doi.org/10.1007/s00380-015-0759-9
67. Ha A. C. T., Hindricks G., Birnie D. H., Verma A. Long-term oral anticoagulation for patients after successful catheter ablation of atrial fibrillation: is it necessary? Curr. Opin. Cardiol., 2015, vol. 30, no. 1, pp. 1-7. https://doi.org/10.1097/HC0.0000000000000121
68. Nattel S., Opie L. H. Controversies in atrial fibrillation. Lancet, 2006, vol. 367, no. 9506, pp. 262-272. https://doi.org/10.1016/S0140-6736(06)68037-9